Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Ar splicing variants and resistance to ar targeting agents
Mayuko Kanayama
, Changxue Lu
, Jun Luo
,
Emmanuel S. Antonarakis
Research output
:
Contribution to journal
›
Review article
›
peer-review
56
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ar splicing variants and resistance to ar targeting agents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Androgen Receptor
100%
Targeted Agents
100%
Splice Variants
100%
Aberrations
42%
Prostate Cancer
28%
Cancer Research
14%
Effective Treatment
14%
Castration-resistant Prostate Cancer
14%
Treatment Options
14%
Androgen Signaling
14%
Drug Resistance
14%
Novel Biomarkers
14%
Adverse Effects
14%
Drug Target
14%
Clinical Utility
14%
Putative Drug Targets
14%
Androgen Receptor Splice Variant
14%
Prognostic Biomarker
14%
Clinical Perspective
14%
Human Specimen
14%
Generation Regulation
14%
Cancer Target
14%
Molecular Perspective
14%
Biomarker-guided Treatment
14%
Treatment Benefit
14%
Immunology and Microbiology
Drug Resistance
100%
Prostate
100%
Therapeutic Target
100%
Medicine and Dentistry
Androgen Receptor
100%
Biological Marker
33%
Prostate Cancer
22%
Clinical Study
11%
Cancer Research
11%
Adverse Event
11%
Castration Resistant Prostate Cancer
11%
Human Specimen
11%
Drug Resistance
11%
Treatment Option
11%
Effective Treatment
11%
Therapeutic Target
11%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Biological Marker
33%
Prostate Cancer
22%
Preclinical Study
11%
Clinical Study
11%
Castration Resistant Prostate Cancer
11%
Adverse Event
11%
Drug Resistance
11%